?
Transfers of Value to Healthcare Professionals

Data Disclosure

In accordance with the EFPIA Disclosure Code Bayer discloses transfers of value connected to the development and commercialization of prescription-only human pharmaceuticals to healthcare professionals and healthcare organizations.

The disclosed data include transfers of value in four main categories

Categories Transfers of value
Healthcare Professionals Healthcare Organizations
Donations and grants Whether monetary or other
Events
  • 1. Registration fees
  • 2. Travel & accommodation
  • 1. Sponsorship
  • 2. Registration fees (if applicable)
  • 3. Travel & accommodation
Services and consultancy
  • 1. Fees
  • 2. Related expenses agreed in the contract (including, for example, travel, accommodation & registration fees)
Research and development Fees, travel & accommodation, and other related expenses that are covered in connection with the service

We at Bayer confirm that our disclosures of transfers of value (ToVs) to HCPs and HCOs have been reported in application of the EFPIA Disclosure Code key principles.

EFPIA Disclosure Code – Signed Self-Certification (PDF, 90.9 KB)

Get Access to the National Data Disclosure

National Data Disclosure

According to the EFPIA Disclosure Code payments, in the majority of countries in Europe, are disclosed on Bayer company global and local websites. In that case links accessible from the list above will be leading directly to the respective country’s data disclosure report available in English and local language.

In other countries, due to the either existing national legislation or legislation in development and country self-regulation, often in partnership with stakeholders, disclosure is required on a central online platform. In that case above links will be leading to the respective country’s disclosure section on the Bayer company local webpage enabling further information.